HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Ator Selected Research

Neuroblastoma

8/2007The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Ator Research Topics

Disease

5Neoplasms (Cancer)
09/2023 - 04/2003
2Prostatic Neoplasms (Prostate Cancer)
09/2023 - 01/2023
2Carcinoma (Carcinomatosis)
08/2007 - 04/2003
2Glioblastoma (Glioblastoma Multiforme)
08/2007 - 04/2003
1Glioma (Gliomas)
08/2007
1Neuroblastoma
08/2007
1Rhabdomyosarcoma
08/2007
1Inflammation (Inflammations)
09/2003
1Granuloma
09/2003
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2003
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2003

Drug/Important Bio-Agent (IBA)

2snake venom protein C activatorIBA
09/2023 - 01/2023
2Proteins (Proteins, Gene)FDA Link
09/2023 - 01/2023
2Irinotecan (Camptosar)FDA LinkGeneric
08/2007 - 04/2003
2Temozolomide (Temodar)FDA LinkGeneric
08/2007 - 04/2003
2CamptothecinIBA
08/2007 - 04/2003
1Androgen Receptors (Androgen Receptor)IBA
01/2023
1Proteolysis Targeting ChimeraIBA
01/2023
1CEP-9722IBA
08/2007
1CEP 8983IBA
08/2007
1Poly Adenosine Diphosphate RiboseIBA
08/2007
1ProdrugsIBA
08/2007
1matrigelIBA
09/2003
1Factor VIII (Coagulation Factor VIII)IBA
09/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2003
1Phosphotransferases (Kinase)IBA
09/2003
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2003
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2003
1N,N-dimethylglycine 3- (5,6,7,13- tetrahydro- 9- ((1- methylethoxy)methyl)- 5- oxo- 12H- indeno(2,1- a)pyrrolo(3,4- c)carbazol- 12- yl)propyl esterIBA
09/2003
1Cisplatin (Platino)FDA LinkGeneric
04/2003
1CEP-6800IBA
04/2003

Therapy/Procedure

2Oral Administration
09/2023 - 01/2023
1Drug Therapy (Chemotherapy)
08/2007
1Therapeutics
04/2003